Literature DB >> 28992857

Anxiety and Depression in Cancer Survivors.

Jean C Yi1, Karen L Syrjala2.   

Abstract

Most cancer survivors adjust well to life after cancer but some experience persisting negative mood, such as cancer-related fears, posttraumatic stress, anxiety, or depression. Mood fluctuations may not reach criteria for a clinical diagnosis but subclinical symptoms can interfere with quality of life. Women, adolescents, and young adults are particularly at risk for mood disturbances. Behavioral interventions, such as cognitive behavioral therapy and pharmacologic treatments, can effectively treat these distressing emotions. Much of the research on managing emotional needs after cancer has been completed with breast cancer survivors and more work is needed with diverse groups of survivors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Cancer survivors; Depression; Distress

Mesh:

Substances:

Year:  2017        PMID: 28992857      PMCID: PMC5915316          DOI: 10.1016/j.mcna.2017.06.005

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  104 in total

1.  Evaluation of Pillars4life: a virtual coping skills program for cancer survivors.

Authors:  Sophia K Smith; Jonathan D O'Donnell; Amy P Abernethy; Kristin MacDermott; Tina Staley; Gregory P Samsa
Journal:  Psychooncology       Date:  2015-01-28       Impact factor: 3.894

2.  Cancer patients with major depressive disorder: testing a biobehavioral/cognitive behavior intervention.

Authors:  Brittany M Brothers; Hae-Chung Yang; Daniel R Strunk; Barbara L Andersen
Journal:  J Consult Clin Psychol       Date:  2011-04

3.  The association between social support and smoking status in cancer survivors with frequent and infrequent mental distress: results from 10 US states, 2010.

Authors:  Hermine Poghosyan; Sabreen A Darwish; Sun S Kim; Mary E Cooley
Journal:  J Cancer Surviv       Date:  2016-05-28       Impact factor: 4.442

4.  Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis.

Authors:  Alex J Mitchell; Nick Meader; Paul Symonds
Journal:  J Affect Disord       Date:  2010-03-05       Impact factor: 4.839

Review 5.  Web based survivorship interventions for women with breast cancer: An integrative review.

Authors:  Kathryn E Post; Jane Flanagan
Journal:  Eur J Oncol Nurs       Date:  2016-11-04       Impact factor: 2.398

6.  Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden.

Authors:  Donghao Lu; Therese M L Andersson; Katja Fall; Christina M Hultman; Kamila Czene; Unnur Valdimarsdóttir; Fang Fang
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

7.  Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.

Authors:  Reina Haque; Jiaxiao Shi; Joanne E Schottinger; Syed A Ahmed; T Craig Cheetham; Joanie Chung; Chantal Avila; Ken Kleinman; Laurel A Habel; Suzanne W Fletcher; Marilyn L Kwan
Journal:  J Natl Cancer Inst       Date:  2015-12-01       Impact factor: 13.506

8.  Investigation of body image as a mediator of the effects of bowel and GI symptoms on psychological distress in female survivors of rectal and anal cancer.

Authors:  Catherine Benedict; Vivian M Rodriguez; Jeanne Carter; Larissa Temple; Christian Nelson; Katherine DuHamel
Journal:  Support Care Cancer       Date:  2015-10-07       Impact factor: 3.603

9.  Selective attention and fear of cancer recurrence in breast cancer survivors.

Authors:  J A E Custers; E S Becker; M F M Gielissen; H W M Van Laarhoven; M Rinck; J B Prins
Journal:  Ann Behav Med       Date:  2015-02

10.  Fear of cancer recurrence in colorectal cancer survivors.

Authors:  José A E Custers; Marieke F M Gielissen; Stephanie H V Janssen; Johannes H W de Wilt; Judith B Prins
Journal:  Support Care Cancer       Date:  2015-06-25       Impact factor: 3.603

View more
  65 in total

1.  Prevalence and factors associated with diagnosed depression among hospitalized cancer patients with metastatic disease.

Authors:  Eric Adjei Boakye; Nosayaba Osazuwa-Peters; Kahee A Mohammed; Sai Challapalli; Paula Buchanan; Thomas E Burroughs; Mark A Varvares
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-08-23       Impact factor: 4.328

2.  Emergency Department Visits for Opioid Overdoses Among Patients With Cancer.

Authors:  Vikram Jairam; Daniel X Yang; James B Yu; Henry S Park
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

Review 3.  Free of malignancy but not of fears: A closer look at Damocles syndrome in survivors of hematologic malignancies.

Authors:  Mohamad S Alabdaljabar; Ibrahim N Muhsen; Jennifer M Knight; Karen L Syrjala; Shahrukh K Hashmi
Journal:  Blood Rev       Date:  2020-12-01       Impact factor: 8.250

4.  Anxiety profiles are associated with stress, resilience and symptom severity in outpatients receiving chemotherapy.

Authors:  Kate Oppegaard; Carolyn S Harris; Joosun Shin; Steven M Paul; Bruce A Cooper; Jon D Levine; Yvette P Conley; Marilyn Hammer; Frances Cartwright; Fay Wright; Laura Dunn; Kord M Kober; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2021-06-26       Impact factor: 3.603

5.  Pain is associated with continuing depression in cancer survivors.

Authors:  Patricia M Bamonti; Jennifer Moye; Aanand D Naik
Journal:  Psychol Health Med       Date:  2018-06-14       Impact factor: 2.423

6.  Psychometric properties and correlates of a brief scale measuring the psychological construct mattering to others in a sample of women recovering from breast cancer.

Authors:  Samantha M Davis; Stephen J Lepore; Levent Dumenci
Journal:  Qual Life Res       Date:  2019-01-25       Impact factor: 4.147

7.  An exercise oncology clinical pathway: Screening and referral for personalized interventions.

Authors:  Nicole L Stout; Justin C Brown; Anna L Schwartz; Timothy F Marshall; Anna M Campbell; Larissa Nekhlyudov; David S Zucker; Karen M Basen-Engquist; Grace Campbell; Jeffrey Meyerhardt; Andrea L Cheville; Kelley R Covington; Jennifer A Ligibel; Jonas M Sokolof; Kathryn H Schmitz; Catherine M Alfano
Journal:  Cancer       Date:  2020-03-25       Impact factor: 6.860

Review 8.  Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigm.

Authors:  Caroline Robert; Aurelien Marabelle; Hugo Herrscher; Caroline Caramella; Pascal Rouby; Karim Fizazi; Benjamin Besse
Journal:  Nat Rev Clin Oncol       Date:  2020-07-07       Impact factor: 66.675

9.  Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis.

Authors:  AnnaLynn M Williams; Carly Paterson Khan; Charles E Heckler; Debra L Barton; Mary Ontko; Jodi Geer; Amber S Kleckner; Shaker Dakhil; Jerry Mitchell; Karen M Mustian; Luke J Peppone; Victor Kipnis; Charles S Kamen; Ann M O'Mara; Michelle C Janelsins
Journal:  Breast Cancer Res Treat       Date:  2021-01-04       Impact factor: 4.872

10.  Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study.

Authors:  James L Rogers; Elizabeth Vera; Alvina Acquaye; Nicole Briceno; Varna Jammula; Amanda L King; Heather Leeper; Martha M Quezado; Javier Gonzalez Alarcon; Lisa Boris; Eric Burton; Orieta Celiku; Anna Choi; Alexa Christ; Sonja Crandon; Ewa Grajkowska; Nicole Leggiero; Nicole Lollo; Marta Penas-Prado; Jennifer Reyes; Christine Siegel; Brett J Theeler; Michael Timmer; Kathleen Wall; Jing Wu; Kenneth Aldape; Mark R Gilbert; Terri S Armstrong
Journal:  Neurooncol Pract       Date:  2021-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.